Related references
Note: Only part of the references are listed.Haptoglobin phenotype, angiogenic factors, and preeclampsia risk
Tracey L. Weissgerber et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women-2011 Update A Guideline From the American Heart Association
Lori Mosca et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Haptoglobin: Basic and Clinical Aspects
Andrew P. Levy et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes
Shany Blum et al.
ATHEROSCLEROSIS (2010)
Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial
David R. McCance et al.
LANCET (2010)
Vitamins C and E to Prevent Complications of Pregnancy-Associated Hypertension.
James M. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype
Shany Blum et al.
PHARMACOGENOMICS (2010)
Haptoglobin phenotype in women with preeclampsia
Rami N. Sammour et al.
ENDOCRINE (2010)
World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries
J. Villar et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2009)
Obstetric and Perinatal Outcomes in Type 1 Diabetic Pregnancies A large, population-based study
Martina Persson et al.
DIABETES CARE (2009)
Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype
Shany Blum et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Vitamin e supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype - A prospective double-blinded clinical trial
Uzi Milman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Haptoglobin genotype - A determinant of cardiovascular complication risk in type 1 diabetes
Tina Costacou et al.
DIABETES (2008)
Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype
Rabea Asleh et al.
DIABETES (2008)
Antioxidant therapy to prevent preeclampsia - A Randomized controlled trial
Joseph A. Spinnato et al.
OBSTETRICS AND GYNECOLOGY (2007)
Involvement of oxidative stress in the pathogenesis of diabetes
Hideaki Kaneto et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Haptoglobin polymorphism in patients with preeclampsia
Herman T. Depypere et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Vitamins C and E and the risks of preeclampsia and perinatal complications
AR Rumbold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial
L Poston et al.
LANCET (2006)
Vitamin C and E supplementation in women at high risk for preeclampsia: A double-blind, placebo-controlled trial
D Beazley et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women
AP Levy et al.
DIABETES CARE (2004)
Outcomes in type 1 diabetic pregnancies - A nationwide, population-based study
DM Jensen et al.
DIABETES CARE (2004)
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes
AP Levy et al.
DIABETES CARE (2004)
Haptoglobin and its association with the HELLP syndrome
MTM Raijmakers et al.
JOURNAL OF MEDICAL GENETICS (2003)
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The strong heart study
AP Levy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
A longitudinal study of biochemical variables in women at risk of preeclampsia
LC Chappell et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial
L Duley et al.
LANCET (2002)
Recent insights into the pathogenesis of pre-eclampsia
JM Roberts et al.
PLACENTA (2002)
Share Paper
